Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This study will consist of a six-week open-label treatment period with an extended duration
methylphenidate (OROS MPH) followed by subsequent monthly visits for 24 months in a large
sample of youths aged 12-17 who meet Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV) criteria for ADHD.
The researchers hypothesize that OROS MPH treatment will be associated with low rates of
cigarette smoking in ADHD youth.